These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 17347873

  • 1. TSH-secreting pituitary adenomas: follow-up of 11 cases and review of the literature.
    Ness-Abramof R, Ishay A, Harel G, Sylvetzky N, Baron E, Greenman Y, Shimon I.
    Pituitary; 2007; 10(3):307-10. PubMed ID: 17347873
    [Abstract] [Full Text] [Related]

  • 2. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 4. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P, Díez JJ.
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 6. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A.
    Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center.
    Nazato DM, Abucham J.
    J Endocrinol Invest; 2018 Apr; 41(4):447-454. PubMed ID: 29022276
    [Abstract] [Full Text] [Related]

  • 9. [Thyrotropin-secreting pituitary adenomas].
    Caron P.
    Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
    [Abstract] [Full Text] [Related]

  • 10. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL.
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM.
    J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF, Liang D, Zhong LY.
    Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
    [Abstract] [Full Text] [Related]

  • 13. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
    Kienitz T, Quinkler M, Strasburger CJ, Ventz M.
    Eur J Endocrinol; 2007 Jul; 157(1):39-46. PubMed ID: 17609400
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 15. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
    Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson CH, Braverman LE, Oldfield EH, Weintraub BD.
    Ann Intern Med; 1989 Nov 15; 111(10):827-35. PubMed ID: 2479309
    [Abstract] [Full Text] [Related]

  • 16. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Nov 15; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 17. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
    Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2005 Feb 15; 62(2):176-81. PubMed ID: 15670193
    [Abstract] [Full Text] [Related]

  • 18. Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature.
    Tong A, Xia W, Qi F, Jin Z, Yang D, Zhang Z, Li F, Xing X, Lian X.
    Thyroid; 2013 Sep 15; 23(9):1172-7. PubMed ID: 23402621
    [Abstract] [Full Text] [Related]

  • 19. Ectopic Suprasellar Thyrotropin-Secreting Pituitary Adenoma: Case Report and Literature Review.
    Wang Q, Lu XJ, Sun J, Wang J, Huang CY, Wu ZF.
    World Neurosurg; 2016 Nov 15; 95():617.e13-617.e18. PubMed ID: 27567574
    [Abstract] [Full Text] [Related]

  • 20. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R.
    Q J Nucl Med; 1995 Dec 15; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.